Lyell Immunopharma, Inc. earnings per share and revenue

LYEL earnings per share for the last quarter are -0.21 USD whereas the estimation was -0.23 USD which accounts for 8.70% surprise. Företagets omsättning för samma period uppgår till 13.00 k USD trots den uppskattade siffran 3.25 k USD. Estimated earnings per share for the next quarter are -0.21 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of LYEL earnings per share and revenue dynamics.